Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-25 @ 4:14 AM
NCT ID:
NCT03311620
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing EBUS TBNA for evaluation of lymphadenopathy, lung nodule or mass
* Patients must have atypical lymph nodes. Atypical lymph nodes are characterized by \>10mm in short axis or lymph nodes 5-10mm in short axis with atypical features.
* Age \> 18 years.
* Patients must have platelets count \> 50,000
* Ability to understand and willingness to sign a written informed consent and HIPAA consent document
* WOCBP must agree not to get pregnant until the day of the procedure
Exclusion Criteria:
* Patients with uncorrectable coagulopathy will be excluded.
* Patients with hemodynamic instability will be excluded
* Patients with refractory hypoxemia will be excluded
* Patients with therapeutic anticoagulant that cannot be held for 2 days before and 1 day after the procedure.
* Patients who are unable to tolerate general anesthesia according to the anesthesiologist
* Pregnant or breast feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03311620
Study Brief:
Protocol Section:
NCT03311620